A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2001
11/21/2001	CN1323346A TPL-2/COT kinase and methods of use
11/21/2001	CN1323314A Inhibitors of caspases
11/21/2001	CN1323309A Phenyl yanthine derivatives
11/21/2001	CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001	CN1323291A Diaminopropionic acid derivatives
11/21/2001	CN1323211A New pharmaceutical uses for NOS inhibitors
11/21/2001	CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001	CN1323206A Fumaric acid microtablets
11/21/2001	CN1323194A UV protection compositions
11/21/2001	CN1323193A UV protection compositions
11/21/2001	CN1322719A MYT1 kinase inhibitor
11/21/2001	CN1322560A Chinese medicine preparation for treating leukoderma and its preparation
11/21/2001	CN1322554A Cream for treating burns, scalds and sore ulcer and its preparation
11/21/2001	CN1322548A Recipe and preparation process of skin itching and pain treating liquid
11/21/2001	CN1322544A External-use Chinese medicine for treating dermatosis
11/21/2001	CN1322537A Preparation of external-use skin care medicine
11/21/2001	CN1322521A Medicated beautifying cream and its making process and use
11/21/2001	CN1075059C Colchicine derivatives and its therapeutical use
11/21/2001	CN1074929C Chilblain paste
11/21/2001	CN1074898C Ionene polymers, producing process, its intermediate and use
11/20/2001	US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death
11/20/2001	US6320054 Thiazole derivatives
11/20/2001	US6320022 Adrenomedullin peptides
11/20/2001	US6319945 Applying ivermectin lotion or cream daily for 7 days and repeating such application one to four times per month for a period of several months.
11/20/2001	US6319939 Retinoic acid mimetic anlides
11/20/2001	US6319934 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319921 Aromatic heterocyclic compound as antiinflammatory agents
11/20/2001	US6319907 Administering latency associated peptide, or a peptide analogue that is capable of maintaining transforming growth factor .beta. in latent state
11/20/2001	US6319906 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
11/20/2001	US6319900 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
11/20/2001	US6319509 Pharmaceutical composition
11/20/2001	US6319507 Topical composition comprising two-phase cream, gel or lotion formed by homogenization at elevated temperature of oil phase, aqueous phase and dispersed gel beads comprising agar gel, restraining polymer distributed throughout gel, active agent
11/20/2001	CA2176668C Heterocyclic spiro compounds, process for preparing the same and pharmaceutical compositions containing them
11/18/2001	CA2348104A1 Composition including manganese
11/18/2001	CA2348102A1 Use of manganese in wrinkle treatment
11/15/2001	WO2001086002A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	WO2001085695A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001	WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085676A1 Biocidal polymers based on guanidine salts
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001	WO2001085256A2 Critical illness neuropathy
11/15/2001	WO2001085194A1 Method and composition for the treatment of angiogenesis
11/15/2001	WO2001085193A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor
11/15/2001	WO2001085192A1 Transgenically produced decorin
11/15/2001	WO2001085184A2 Nontoxic vernix compositions and method of producing
11/15/2001	WO2001085182A2 Combined cartilage and plant extract compositions
11/15/2001	WO2001085181A1 Therapeutical composition comprising iodine tincture, alcohol and castor oil for treatment of psoriasis
11/15/2001	WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001	WO2001085163A1 Treating eczema and/or psoriasis
11/15/2001	WO2001085161A1 Combination preparation consisting of φ-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
11/15/2001	WO2001085156A1 Dermal compositions containing coenzyme q as the active ingredient
11/15/2001	WO2001085151A2 Chimeric animal model and treatment of psoriasis
11/15/2001	WO2001085128A2 Skin protectant spray compositions
11/15/2001	WO2001085096A2 Mast cell regulation
11/15/2001	WO2001084929A1 Antitubulin assembly and cell growth inhibitor denominated 'dioxostatin'
11/15/2001	WO2001040185B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
11/15/2001	WO2001034601A3 Imidazopyridine derivatives as phosphodiesterase vii inhibitors
11/15/2001	WO2001016136B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
11/15/2001	WO2001000880A3 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
11/15/2001	WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001	WO2000047729A9 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/15/2001	WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	US20010041718 Cis-6-(4-fluoro-phenyl)-5-(4-(2-piperidin-1-yl-ethoxy)-phenyl) -5,6,7,8-tetrahydronaphthalene-2-ol, for example, and other estrogen agonists/antagonists to treat rheumatoid arthritis, colon cancer, wounds, cataracts and skin wrinkles
11/15/2001	US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001	US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001	US20010041696 Cosmetic or dermatological use of 7-hydroxylated steroids
11/15/2001	US20010041193 Mixture of ascorbic acid, zinc salt and tyrosine compound
11/15/2001	US20010041191 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate
11/15/2001	US20010041170 Compounds with chelation affinity and selectivity for first transition series elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
11/15/2001	CA2409759A1 Method and composition for the treatment of angiogenesis
11/15/2001	CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001	CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408544A1 Combined marine and plant extract compositions
11/15/2001	CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	CA2408352A1 Nontoxic vernix compositions and method of producing
11/15/2001	CA2408349A1 Method of regulating angiogenesis unsing ryk protein
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408253A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/15/2001	CA2408228A1 Method for promoting neovascularization
11/15/2001	CA2408220A1 Antitubulin assembly and cell growth inhibitor denominated "dioxostatin"
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408124A1 Transgenically produced decorin
11/15/2001	CA2408112A1 Skin protectant spray compositions
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins

1 ... 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 ... 1065